Publikationen von 0000-0003-1783-133X
(ORCID: 0000-0003-1783-133X)
 | Eine Stufe nach oben |
Anzahl der Einträge: 2.
2018
Schmitz-Winnenthal, Friedrich H., Hohmann, Nicolas 
, Schmidt, Thomas , Podola, Lilli, Friedrich, Tobias, Lubenau, Heinz, Springer, Marco, Wieckowski, Sébastien, Breiner, Klaus M., Mikus, Gerd , Büchler, Markus W., Keller, Anne-Valerie, Koc, Ruhan, Springfeld, Christoph , Knebel, Phillip, Bucur, Mariana, Grenacher, Lars, Haefeli, Walter E. und Beckhove, Philipp
(2018)
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.
OncoImmunology 7 (4), e1303584.
Volltext nicht vorhanden.
, Schmidt, Thomas , Podola, Lilli, Friedrich, Tobias, Lubenau, Heinz, Springer, Marco, Wieckowski, Sébastien, Breiner, Klaus M., Mikus, Gerd , Büchler, Markus W., Keller, Anne-Valerie, Koc, Ruhan, Springfeld, Christoph , Knebel, Phillip, Bucur, Mariana, Grenacher, Lars, Haefeli, Walter E. und Beckhove, Philipp
(2018)
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.
OncoImmunology 7 (4), e1303584.
Volltext nicht vorhanden.
2006
Kees, Frieder, Bucher, Michael, Schweda, Frank, Gschaidmeier, Harald, Burhenne, Juergen , Mikus, Gerd und Faerber, Lothar
(2006)
Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
Therapeutic drug monitoring 28 (3), S. 312-320.
Zugang zum Volltext eingeschränkt.
, Mikus, Gerd und Faerber, Lothar
(2006)
Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
Therapeutic drug monitoring 28 (3), S. 312-320.
Zugang zum Volltext eingeschränkt.